Peter Matthiessen,Gerald T Ankley,Ronald C Biever,Poul Bjerregaard,Christopher Borgert,Kristin Brugger,Amy Blankinship,Janice Chambers,Katherine K Coady,Lisa Constantine,Zhichao Dang,Nancy D Denslow,David A Dreier,Steve Dungey,L Earl Gray,Melanie Gross,Patrick D Guiney,Markus Hecker,Henrik Holbech,Taisen Iguchi,Sarah Kadlec,Natalie K Karouna‐Renier,Ioanna Katsiadaki,Yukio Kawashima,Werner Kloas,Henry Krueger,Anu Kumar,Laurent Lagadic,Annegaaike Leopold,Steven L Levine,Gerd Maack,Sue Marty,James Meador,Ellen Mihaich,Jenny Odum,Lisa Ortego,Joanne Parrott,Daniel Pickford,Mike Roberts,Christoph Schaefers,Tamar Schwarz,Keith Solomon,Tim Verslycke,Lennart Weltje,James R Wheeler,Mike Williams,Jeffrey C Wolf,Kunihiko Yamazaki,Natalie K Karouna-Renier

Abstract:A SETAC Pellston Workshop® "Environmental Hazard and Risk Assessment Approaches for Endocrine-Active Substances (EHRA)" was held in February 2016 in Pensacola, Florida, USA. The primary objective of the workshop was to provide advice, based on current scientific understanding, to regulators and policy makers; the aim being to make considered, informed decisions on whether to select an ecotoxicological hazard- or a risk-based approach for regulating a given endocrine-disrupting substance (EDS) under review. The workshop additionally considered recent developments in the identification of EDS. Case studies were undertaken on 6 endocrine-active substances (EAS-not necessarily proven EDS, but substances known to interact directly with the endocrine system) that are representative of a range of perturbations of the endocrine system and considered to be data rich in relevant information at multiple biological levels of organization for 1 or more ecologically relevant taxa. The substances selected were 17α-ethinylestradiol, perchlorate, propiconazole, 17β-trenbolone, tributyltin, and vinclozolin. The 6 case studies were not comprehensive safety evaluations but provided foundations for clarifying key issues and procedures that should be considered when assessing the ecotoxicological hazards and risks of EAS and EDS. The workshop also highlighted areas of scientific uncertainty, and made specific recommendations for research and methods-development to resolve some of the identified issues. The present paper provides broad guidance for scientists in regulatory authorities, industry, and academia on issues likely to arise during the ecotoxicological hazard and risk assessment of EAS and EDS. The primary conclusion of this paper, and of the SETAC Pellston Workshop on which it is based, is that if data on environmental exposure, effects on sensitive species and life-stages, delayed effects, and effects at low concentrations are robust, initiating environmental risk assessment of EDS is scientifically sound and sufficiently reliable and protective of the environment. In the absence of such data, assessment on the basis of hazard is scientifically justified until such time as relevant new information is available. Integr Environ Assess Manag 2017;13:267-279. © 2017 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC).

Advancing Endocrine Disruptors via In Vitro Evaluation: Recognizing the Significance of the Organization for Economic Co-Operation and Development and United States Environmental Protection Agency Guidelines, Embracing New Assessment Methods, and the Urgent Need for a Comprehensive Battery of Tests

Towards regulation of Endocrine Disrupting chemicals (EDCs) in water resources using bioassays - A guide to developing a testing strategy

The benefits of validation of methods for toxicity testing outweigh its costs

Using alternative test methods to predict endocrine disruption and reproductive adverse outcomes: do we have enough knowledge?

Assessment of endocrine disruptive properties of PFOS: EFSA/ECHA guidance case study utilising AOP networks and alternative methods

Peer-reviewed and unbiased research, rather than ‘sound science’, should be used to evaluate endocrine-disrupting chemicals

Endocrine Disruptors: Time to Act

The regulation of endocrine-disrupting chemicals to minimize their impact on health

Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs

Thresholds and Endocrine Disruptors: An Endocrine Society Policy Perspective

Thresholds of adversity for endocrine disrupting substances: a conceptual case study

Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances

Determining the endocrine disruption potential of industrial chemicals using an integrative approach: Public databases, in vitro exposure, and modeling receptor interactions

Enhanced identification of endocrine disruptors through integration of science-based regulatory practices and innovative methodologies: The MERLON Project

An Integrated "4-Phase" Approach for Setting Endocrine Disruption Screening Priorities--phase I and II Predictions of Estrogen Receptor Binding Affinity

Endocrine disruption assessment in aquatic vertebrates - Identification of substance-induced thyroid-mediated effect patterns

Trans-disciplinary diagnosis for an in-depth reform of regulatory expertise in the field of environmental toxicology and security

Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

New approaches for assessing the etiology and risks of developmental abnormalities from chemical exposure

Endocrine disrupting chemicals: Impact on human health, wildlife and the environment

Resource and animal use implications of the proposed REACH information requirements for endocrine disruptor assessment